These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9360060)

  • 1. Clopidogrel.
    Coukell AJ; Markham A
    Drugs; 1997 Nov; 54(5):745-50; discussion 751. PubMed ID: 9360060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel: a review of its use in the prevention of atherothrombosis.
    Jarvis B; Simpson K
    Drugs; 2000 Aug; 60(2):347-77. PubMed ID: 10983738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Hankey GJ; Sudlow CL; Dunbabin DW
    Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
    CAPRIE Steering Committee
    Lancet; 1996 Nov; 348(9038):1329-39. PubMed ID: 8918275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events.
    Harker LA; Boissel JP; Pilgrim AJ; Gent M
    Drug Saf; 1999 Oct; 21(4):325-35. PubMed ID: 10514023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel: the future choice for preventing platelet activation during coronary stenting?
    Gurbel PA; O'Connor CM; Cummings CC; Serebruany VL
    Pharmacol Res; 1999 Aug; 40(2):107-11. PubMed ID: 10433868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel: a review of its use in the prevention of thrombosis.
    Plosker GL; Lyseng-Williamson KA
    Drugs; 2007; 67(4):613-46. PubMed ID: 17352522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y12, a new platelet ADP receptor, target of clopidogrel.
    Herbert JM; Savi P
    Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel: new preparation. An alternative to aspirin.
    Prescrire Int; 1999 Dec; 8(44):163-4. PubMed ID: 11503810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet drugs in secondary prevention after acute myocardial infarction.
    Thizon-de-Gaulle I
    Rev Port Cardiol; 1998 Dec; 17(12):993-7. PubMed ID: 9973860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel use in coronary artery disease.
    Baggish AL; Sabatine MS
    Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):7-15. PubMed ID: 16375623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel: potential in the prevention of cardiovascular events in patients with acute coronary syndromes.
    Easthope SE; Jarvis B
    Am J Cardiovasc Drugs; 2001; 1(6):467-74; discussion 475-6. PubMed ID: 14728005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
    David JL; Limet R
    Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Olędzki S; Kornacewicz-Jach Z; Safranow K; Kiedrowicz R; Gawrońska-Szklarz B; Jastrzębska M; Gorący J
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1085-1094. PubMed ID: 28589365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events.
    Creager MA
    Vasc Med; 1998; 3(3):257-60. PubMed ID: 9892520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
    Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
    Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel for cerebrovascular prevention.
    Paciaroni M; Bogousslavsky J
    Cerebrovasc Dis; 1999; 9(5):253-60. PubMed ID: 10473907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current pharmacological principles to inhibit platelet function and their clinical implications. Focus on clopidogrel].
    Schrör K
    Med Klin (Munich); 2004 Aug; 99 Suppl 1():3-7. PubMed ID: 15487851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
    Erlinge D; Gurbel PA; James S; Lindahl TL; Svensson P; Ten Berg JM; Foley DP; Wagner H; Brown PB; Luo J; Zhou C; Moser BA; Jakubowski JA; Small DS; Winters KJ; Angiolillo DJ
    J Am Coll Cardiol; 2013 Aug; 62(7):577-83. PubMed ID: 23747759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.